Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serotonin and the heart.

W H Frishman1, P Grewall

  • 1Department of Medicine, New York Medical College, Valhalla 10595, USA. joanne_pryor@nymc.edu

Annals of Medicine
|May 23, 2000
PubMed
Summary

Selective 5-HT2 serotonergic receptor blockers show potential as vasodilators for cardiovascular diseases. However, potential risks like ECG QT interval prolongation require careful patient monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AIDS and the heart: Clinicopathologic assessment.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

ACE inhibitors and the arterial wall. Introduction.

Postgraduate medicine·2009
Same author

Pathophysiology and medical management of systemic hypertension and pre-eclampsia in pregnancy.

Minerva medica·2006
Same author

Antiplatelet therapy: glycoprotein IIb/IIIa receptor antagonists.

Drugs of today (Barcelona, Spain : 1998)·2003
Same author

Alcohol as a cardioprotective agent.

Heart disease (Hagerstown, Md.)·2002
Same author

Cardiopulmonary resuscitation 2000.

Heart disease (Hagerstown, Md.)·2002

Area of Science:

  • Cardiovascular Pharmacology
  • Neuropharmacology

Background:

  • Serotonin exerts diverse cardiophysiological effects via receptor subtypes.
  • Serotonin's vasoconstrictive actions are mediated by 5-HT2 receptors, amplifying other vasoconstrictors.
  • Serotonergic system abnormalities are implicated in cardiovascular diseases like hypertension and peripheral vascular disease.

Purpose of the Study:

  • To explore the therapeutic potential of selective 5-HT2 serotonergic receptor blockers in cardiovascular disease states.
  • To highlight the vasodilatory properties of these agents.

Main Methods:

  • Review of existing clinical experience and ongoing investigations of selective 5-HT2 serotonergic receptor blockers.
  • Focus on agents like ketanserin.

Main Results:

  • Selective 5-HT2 serotonergic receptor blockers demonstrate potent vasodilatory effects.
  • Ketanserin has the largest accumulated clinical experience among these agents.

Conclusions:

  • Selective 5-HT2 serotonergic receptor blockers offer therapeutic promise for various cardiovascular conditions.
  • Potential risks, including ECG QT interval prolongation, necessitate careful consideration and monitoring in patient treatment.

Related Experiment Videos